Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL

Catalog number BNC743792-100

Price for BNC743792-100

Size / count 1x 100 µL

About this product

Recognizes a protein of about 37 kDa, which is identified as Erythropoietin (EPO) . Erythropoietin is a secreted, glycosylated cytokine hormone composed of four alpha helical bundles. It is the primary factor responsible for regulating erythropoiesis during steady-state conditions and in response to blood loss and hemorrhage in the adult organism. Erythropoietin is synthesized by the kidney and stimulates the proliferation and maturation of bone marrow erythroid precursor cells. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC743792-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: EP; EPO alpha; EPO; Epoetin; Erythropoietin; MVCD2
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: EPO
Gene ID: 2056
NCBI Gene ID: 2303
UniProt: P01588
Swiss Prot: P01588
Host: Mouse
Species Reactivity: Human
Reactivity: Erythropoietin
Immunogen: Recombinant fragment (around aa 28-162) of human EPO protein (exact sequence is proprietary)
Target Antigen: Erythropoietin
Clonality: Recombinant Monoclonal
Clone: REPO/1367
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Positive Control: HepG2 Cells. Heart or Kidney.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% rBSA, 0.05% azide
Molecular Weight: 37 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF740

Frequently Asked Questions

What is the catalog number for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL?

The catalog number for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL is BNC743792-100.

What sizes are available for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL?

Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL in stock?

Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL?

Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL?

Estimated delivery time for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL?

The safety data sheet for Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is Erythropoietin (EPO) (Marker of Placentation Disorders) (rEPO/1367), CF740 conjugate, 0.1mg/mL used for?

What is the difference between this product and a similar catalogue number?

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Do you offer custom or private-label production of this type of product?

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

What is the immunogen used to generate this antibody?

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.